Ignite Creation Date:
2024-05-05 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00482508
Status:
COMPLETED
Last Update Posted:
2011-10-25
First Post:
2007-06-04
Brief Title:
Safety and Tolerability of Omalizumab in Poorly Controlled Moderate to Severe Asthma Patients
Sponsor:
Novartis
Organization:
Novartis